Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04943172 · ClinicalTrials.gov registry record · NA
The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study
A NA study of Deep Venous Insufficiency (Diagnosis), sponsored by Hancock Jaffe Laboratiores.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 20
- Study locations
NCT04943172 is a NA study of Deep Venous Insufficiency (Diagnosis) that is active but no longer recruiting, run by Hancock Jaffe Laboratiores. The registered enrollment target is 75 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT04943172, a NA study of Deep Venous Insufficiency (Diagnosis), is active but no longer recruiting, sponsored by Hancock Jaffe Laboratiores.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, non blinded, single arm, multicenter study designed to assess the safety and effectiveness of the bioprosthetic, VenoValve, which is surgically implanted into the deep venous system for treatment of patients with deep venous valvular insufficiency ( C4b-C6 patients).
Conditions Studied
Interventions
- DEVICE Hancock-Jaffe bioprosthetic venous valve (VenoValve®)
Study Locations (20)
New York
- Albany Medical Center - Albany
- Kaleidahealth - Buffalo
- NYU Langone - New York
- Mount Sinai Hospital - New York
- Stony Brook Medicine - New York
- St. Peter's Vascular Associates - Troy
Florida
- Coastal Vascular - Fort Walton Beach
- Miami Vascular Specialists - Miami
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Pima Heart and Vascular - Tucson
California
- Cedars-Sinai Medical Center - Beverly Hills
Connecticut
- Yale school of Medicine - New Haven
Illinois
- University of Chicago - Chicago
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04943172
The ClinicalTrials.gov registry entry for NCT04943172 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hancock Jaffe Laboratiores, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Deep Venous Insufficiency (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which Hancock-Jaffe bioprosthetic venous valve (VenoValve®) is the first listed.
NCT04943172 reports 20 study locations spanning 14 distinct geographic areas - top geographies include New York, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT04943172 about?
NCT04943172 is a clinical study titled "The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study". A prospective, non blinded, single arm, multicenter study designed to assess the safety and effectiveness of the bioprosthetic, VenoValve, which is surgically implanted into the deep venous system for treatment of patients with deep venous valvular insufficiency ( C4b-C6 patients).
What is the current status of trial NCT04943172?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2021-08-27. Estimated completion is 2028-03.
What conditions does trial NCT04943172 study?
This clinical trial studies the following conditions: Deep Venous Insufficiency (Diagnosis).
What interventions are being tested in trial NCT04943172?
The interventions under investigation include: Hancock-Jaffe bioprosthetic venous valve (VenoValve®) (DEVICE).
Who is sponsoring clinical trial NCT04943172?
This trial is sponsored by Hancock Jaffe Laboratiores, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04943172 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.